Equities

Lupin Ltd

Lupin Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)2,107.15
  • Today's Change42.60 / 2.06%
  • Shares traded990.40k
  • 1 Year change+69.54%
  • Beta0.7375
Data delayed at least 15 minutes, as of Nov 25 2024 10:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments20,34517,17619,123
Total Receivables, Net59,32157,02555,879
Total Inventory51,99946,61348,273
Prepaid expenses9991,136997
Other current assets, total1,8132,563305
Total current assets134,477124,513124,577
Property, plant & equipment, net54,94255,39853,973
Goodwill, net23,25022,18821,241
Intangibles, net18,31618,34610,065
Long term investments2,2777711,555
Note receivable - long term2,7185,4134,995
Other long term assets795810--
Total assets239,972229,559218,212
LIABILITIES
Accounts payable29,58125,31522,829
Accrued expenses4,1933,4333,117
Notes payable/short-term debt26,69942,16537,023
Current portion long-term debt/capital leases9661,111923
Other current liabilities, total23,57720,62918,873
Total current liabilities85,01592,65482,764
Total long term debt1,5532,1393,638
Total debt29,21845,41541,584
Deferred income tax2,4592,2942,408
Minority interest832783687
Other liabilities, total7,2117,0447,182
Total liabilities97,069104,91496,680
SHAREHOLDERS EQUITY
Common stock911910909
Additional paid-in capital11,79411,07610,620
Retained earnings (accumulated deficit)130,689113,301110,727
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(1636)(2131)(2341)
Total equity142,903124,645121,533
Total liabilities & shareholders' equity239,972229,559218,212
Total common shares outstanding456455454
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.